pI: 6.4043 |
Length (AA): 244 |
MW (Da): 26883 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Bloodstream Form. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127825)
Species | Accession | Gene Product |
---|---|---|
Candida albicans | CaO19.10480 | similar to archaebacterial Sir2 family protein |
Candida albicans | CaO19.2963 | similar to archaebacterial Sir2 family protein |
Dictyostelium discoideum | DDB_G0286671 | NAD(+)-dependent deacetylase, silent information regulator protein family protein |
Dictyostelium discoideum | DDB_G0270928 | NAD(+)-dependent deacetylase, silent information regulator protein family protein |
Escherichia coli | b1120 | deacetylase of acs and cheY, chemotaxis regulator |
Entamoeba histolytica | EHI_007500 | Sir2 family transcriptional regulator, putative |
Giardia lamblia | GL50803_16569 | Transcriptional regulator, Sir2 family |
Homo sapiens | ENSG00000124523 | sirtuin 5 |
Leishmania braziliensis | LbrM.20.1640 | NAD dependent deacetylase, putative,transcriptional regulator, Sir2 family protein, nicotinic acid mononucleotide 5,6-dimethylbe |
Leishmania donovani | LdBPK_341900.1 | Silent information regulator 2 related protein 3 |
Leishmania infantum | LinJ.34.1900 | NAD dependent deacetylase, putative,transcriptional regulator, Sir2 family protein, nicotinic acid mononucleotide 5,6-dimethylbe |
Leishmania major | LmjF.34.2140 | NAD dependent deacetylase, putative,transcriptional regulator, Sir2 family protein, nicotinic acid mononucleotide 5,6-dimethylbe |
Leishmania mexicana | LmxM.33.2140 | NAD dependent deacetylase, putative,transcriptional regulator, Sir2 family protein, nicotinic acid mononucleotide 5,6-dimethylbe |
Mycobacterium leprae | ML1511 | Probable NAD-dependent deacetylase NpdA (Regulatory protein SIR2 homolog) |
Mus musculus | ENSMUSG00000054021 | sirtuin 5 |
Mycobacterium tuberculosis | Rv1151c | Transcriptional regulatory protein |
Mycobacterium ulcerans | MUL_0992 | NAD-dependent deacetylase |
Neospora caninum | NCLIV_045990 | NAD-dependent deacetylase, putative |
Plasmodium berghei | PBANKA_1343800 | transcriptional regulatory protein sir2a |
Plasmodium falciparum | PF3D7_1328800 | transcriptional regulatory protein sir2a |
Plasmodium knowlesi | PKNH_1271600 | transcriptional regulatory protein sir2 homologue, putative |
Plasmodium vivax | PVX_082385 | NAD-dependent deacetylase, putative |
Plasmodium yoelii | PY01554 | transcriptional regulatory protein, Sir2 family |
Schistosoma japonicum | Sjp_0075430 | ko:K01463 sirtuin 5 (silent mating type information regulation 2 homolog) 5 [EC:3.5.1.-], putative |
Schistosoma mansoni | Smp_055090 | chromatin regulatory protein sir2 |
Schmidtea mediterranea | mk4.005077.00 | NAD-dependent protein deacylase sirtuin-5, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.4.2480 | NAD dependent deacetylase, putative,transcriptional regulator, Sir2 family protein, nicotinic acid mononucleotide 5,6-dimethylbe |
Trypanosoma brucei | Tb927.4.2520 | Silent information regulator 2 related protein 3 |
Trypanosoma congolense | TcIL3000_0_08380 | Silent information regulator 2 related protein 3 |
Trypanosoma cruzi | TcCLB.506559.80 | Silent information regulator 2 related protein 3 |
Trypanosoma cruzi | TcCLB.447255.20 | Silent information regulator 2 related protein 3 |
Toxoplasma gondii | TGME49_227020 | histone deacetylase SIR2 |
Trichomonas vaginalis | TVAG_016210 | chromatin regulatory protein sir2, putative |
Trichomonas vaginalis | TVAG_480900 | chromatin regulatory protein sir2, putative |
Trichomonas vaginalis | TVAG_256040 | chromatin regulatory protein sir2, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1171 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.4.2520 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.2520 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.2520 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.4.2520 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1120 | Escherichia coli | non-essential | goodall |
PBANKA_1343800 | Plasmodium berghei | Dispensable | plasmo |
TGME49_227020 | Toxoplasma gondii | Probably non-essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | sirtuin 5 | Compounds | References |
7 literature references were collected for this gene.